Worth reading
65In focus
Scored from 3 of 6 sectionsDirection
Improvement
Direction inferred from the company’s description.Scale
167
¥ millionWording
Conditional
How definitive the wording is.Contents of this document
Earnings presentationFiscal year ending March 20265 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥66,692 million+2.4%
Operating profit¥2,482 million+17.6%
Ordinary income¥2,934 million+18.4%
Net income¥2,362 million+7.6%
Selling, general and administrative expenses¥7,135 million
Full-year earnings forecast
Fiscal Period CoveredFiscal year ending March 2027
Net Sales
¥70,100 million
Operating profit
¥2,610 million
Ordinary income
¥3,110 million
Profit attributable to owners of the parent
¥2,450 million
Earnings per share
¥107.34
What the company explained in this material
New initiatives
- Improving the utilization and profitability of existing investment facilities
- Developing businesses in line with changes in the external environment
- Initiatives to improve capital efficiency
Segment results
- Chemicals BusinessNet Sales¥44,319 million (YoY +2.1%)Segment profit¥3,942 million (YoY +5.1%)
- Functional Materials BusinessNet Sales¥14,490 million (YoY +5.7%)Segment profit¥831 million (YoY +3.0%)
- Other businessesNet Sales¥7,882 million (YoY -1.8%)Segment profit¥244 million (YoY +55.5%)
Medium-term management plan targets
DetailsEstablishing a standard payout ratio of 40% or higher
Target fiscal yearFiscal year ending March 2027
Annual Dividend
Fiscal year ending March 2026
Annual¥44
Interim¥20
End of period¥24
Forecast for the fiscal year ending March 2027
Annual¥44
Interim¥22
End of period¥22
Payout ratio
Target40% or more
Fiscal year ending March 202640.2 %
| Item | Details |
|---|---|
| Document type | Earnings presentation |
| Fiscal Period Covered | Fiscal year ending March 2026 |
| Net Sales | ¥66,692 million (YoY +2.4%) |
| Operating profit | ¥2,482 million (YoY +17.6%) |
| Ordinary income | ¥2,934 million (YoY +18.4%) |
| Net income | ¥2,362 million (YoY +7.6%) |
| Selling, general and administrative expenses | ¥7,135 million |
| Full-year earnings forecast | Fiscal Period Covered Fiscal year ending March 2027 / Net Sales ¥70,100 million / Operating profit ¥2,610 million / Ordinary income ¥3,110 million / Profit attributable to owners of the parent ¥2,450 million / Earnings per share ¥107.34 |
| Segment results | Segment Chemicals Business / Net Sales ¥44,319 million (YoY +2.1%) / Segment profit ¥3,942 million (YoY +5.1%), Segment Functional Materials Business / Net Sales ¥14,490 million (YoY +5.7%) / Segment profit ¥831 million (YoY +3.0%), Segment Other businesses / Net Sales ¥7,882 million (YoY -1.8%) / Segment profit ¥244 million (YoY +55.5%) |
| Medium-term management plan targets | Details Establishing a standard payout ratio of 40% or higher / Target fiscal year Fiscal year ending March 2027 |
| Annual Dividend | Fiscal year ending March 2026 Annual ¥44 / Interim ¥20 / End of period ¥24 / Forecast for the fiscal year ending March 2027 Annual ¥44 / Interim ¥22 / End of period ¥22 |
| Payout ratio | Target 40% or more / Fiscal year ending March 2026 40.2 % |
| New initiatives | Improving the utilization and profitability of existing investment facilities, Developing businesses in line with changes in the external environment, Initiatives to improve capital efficiency |
Items this document does not state (18)
Gross Profit MarginOperating profit marginResults for the three months of the current quarterProgress against full-year forecastSelf-assessment against the planBreakdown of Factors Affecting the ChangeKey KPIsUnit price and quantity metricsNumber of stores and locationsNumber of employeesAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookFinancial targetsAcquisition of treasury sharesCapital expendituresOrders received and order backlogMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Strong orders for inorganic chemicals for the electronics industry and government agencies, stable chemical market conditions, and increased sales of packaging-related equipment contributed to higher revenue and profits. Operating income increased as revenue from business activities grew, while net income increased in line with the rise in operating income.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.